Clinical Trial Update: Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating boceprevir in combination with standard hepatitis C therapy in people with and without HIV was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• Hepatitis C

Drugs mentioned

• Victrelis (boceprevir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hepatitis, HIV/AIDS | Phase 4 | Status: TERMINATED | Results posted: 2015-07-13